Clinical Trial Update: A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Through Less Invasive Surfactant Administration (LISA) and Conventional Administration [Phase 3]

View source ↗

Summary

Phase 3 study comparing CUROSURF administration via less invasive surfactant administration (LISA) versus conventional administration in preterm neonates with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Curosurf (poractant alfa)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Respiratory Distress Syndrome (RDS) | Phase 3 | Status: TERMINATED | Results posted: 2023-11-03